Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
ランチビオチックペプチド系アポトーシスイメージング剤
Document Type and Number:
Japanese Patent JP2013538819
Kind Code:
A
Abstract:
The present invention relates to radiopharmaceutical imaging in vivo of apoptosis. The invention provides imaging agents which target apoptotic cells via selective binding to the aminophospholipid phosphatidylethanolamine (PE), which is exposed on the surface of apoptotic cells. The radiopharmaceuticals comprise radiometal complexes of chelator conjugates of PE-binding peptides. Also provided are pharmaceutical compositions, kits and methods of in vivo imaging.

More Like This:
JPS6219536435S-LABELLED 1,4-DIHYDROPYRIDINES
WO/2000/040275THE PREPARATION AND USE OF RADIUM-223 TO TARGET CALCIFIED TISSUES FOR PAIN PALLIATION, BONE CANCER THERAPY, AND BONE SURFACE CONDITIONING
JP2023062146ASTATINE SOLUTION AND METHOD FOR PRODUCING THE SAME
Inventors:
Indrevol, bird
Hiscock, Duncan
Arbo, Bente Elizabeth
Vara, Rajiv
Glazer, Matthias Everbird
Macroby, Graham Walter
Application Number:
JP2013529674A
Publication Date:
October 17, 2013
Filing Date:
September 27, 2011
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
GE HEALTHCARE LIMITED
International Classes:
A61K51/00; C07K7/08
Attorney, Agent or Firm:
Arakawa Satoshi
Hirokazu Ogura
Toshihisa Kurokawa



 
Previous Patent: 気分障害のインビボイメージング方法

Next Patent: マトリックスメタロプロテイナーゼ阻害剤